OSI Pharma (OSIP) Rejects Astellas' $52/Share Cash Acquistion Bid

March 15, 2010 8:38 AM EDT Send to a Friend
OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) today announced that its Board of Directors, after careful review and consideration with the assistance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login